Our Applications

A label-free, gentle sorting platform isolates only microgels containing viable therapeutic cells, enabling the rapid fabrication of implantable tissues that achieve durable, physiological function — as demonstrated by over 3 months of euglycemia in diabetic rodents.

Bio-artificial Tissue Assembly for Cell-Based Therapies

A multi-modal brightfield/fluorescence system with proprietary AI models selects high-yield producer cells for industrial biosynthesis, dramatically compressing iteration times (hours instead of months) and enabling gram-scale production of antibodies, enzymes, and sustainable biochemicals.

AI-Enhanced Bioproduction Screening

An intelligent sorting platform performs longitudinal, multi-parametric analysis of tumour cells in hydrogel droplets, facilitating patient-specific cancer vaccine testing, onco-therapeutic validation, and real-time monitoring of intratumoral heterogeneity.

Time-Resolved Personalised Oncology Profiling

RBS’s cell‑friendly platform underpins full‑potency bio‑artificial pancreas and liver constructs that avoid empty‑capsule attrition, high‑throughput biomolecule and antibody manufacture, and time‑resolved precision oncology—collapsing the gap from discovery to clinical‑ and industrial‑scale production.